- NSE
- ORCHPHARMA
- ISIN
- INE191A01027
ORCHID PHARMA
Healthcare· Pharmaceuticals & Biotechnology· Pharmaceuticals
₹884.00
+₹16.00 (+1.84%)
NSE close ·
ORCHID PHARMA closed at ₹884.00 on 9 Nov 2026, up 1.84% on the day, and is up 6.54% over the past year.
Price history
Between 10 Nov 2025 and 9 Nov 2026, the closing price ranged from ₹482.45 to ₹1,107.20.
Price returns, excl. dividends. 3Y, 5Y and Max are annualised.
Fundamentals
- Market cap
- ₹5,294 Cr
- Industry P/E
- 35.5
Market cap at the 9 Nov 2026 close. Industry P/E is the median of 21 Pharmaceuticals & Biotechnology stocks.
Quarterly results
| Quarter | Revenue | Net profit | YoY profit | EPS |
|---|---|---|---|---|
| Jun 2026 | ₹306 Cr | ₹3.22 Cr | — | ₹0.54 |
Armor risk check
ORCHID PHARMA moves about 3× as much as the market
Volatility, past year
Worst fall, past year
Compared with the Nifty 500 over the past 12 months.
Check it against your portfolio in the appFAQs
What is ORCHID PHARMA's share price today?
ORCHID PHARMA (NSE: ORCHPHARMA) closed at ₹884.00 on 9 Nov 2026, up 1.84% from the previous close of ₹868.00. It traded between ₹881.05 and ₹914.00 that day.
What are ORCHID PHARMA's 52-week high and low?
Over the last 52 weeks ORCHID PHARMA traded between ₹480.00 and ₹1,143.50, adjusted for splits and bonuses.
What are ORCHID PHARMA's NSE symbol, BSE code and ISIN?
ORCHID PHARMA has NSE symbol ORCHPHARMA, ISIN INE191A01027.
How has ORCHID PHARMA performed over 1, 3 and 5 years?
ORCHID PHARMA's share price return: 1Y +6.54%, 3Y +17.71% a year, 5Y +16.83% a year. Dividends are not included.
What is ORCHID PHARMA's market cap?
ORCHID PHARMA's market cap is ₹5,294 Cr at the close on 9 Nov 2026.
Which sector is ORCHID PHARMA in?
ORCHID PHARMA is in NSE's Healthcare sector, in the Pharmaceuticals & Biotechnology industry (Pharmaceuticals).
For information only. Not investment advice or a research report. Past performance does not guarantee future returns.
Full disclaimerSee how ORCHID PHARMA fits your plan
Armor checks every holding against your goals, risk and timeline.
Get the app